Leila Alland
CIK 1825216 · View on SEC EDGAR ↗
Insider
First SEC filing: Sept. 24, 2020 · Latest: Sept. 24, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net:
$-65,120
+ 18 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
18 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2026 | ABEO | S | 11,000 | $5.92 | $65,120 | 162,614 Direct | -6.34% | Disposed | 3.2% (price as of 2026-08-21) |
| Sept. 15, 2023 | PMVP | S | 6,291 | $6.62 | $41,646 | 45,909 Direct | -12.05% | Disposed | -80.0% (price as of 2026-08-21) |
| Sept. 9, 2021 | PMVP | S 10b5-1 | 100 | $30.25 | $3,025 | 0 Direct | -100.00% | Disposed | -95.6% (price as of 2026-08-21) |
| Sept. 7, 2021 | PMVP | S 10b5-1 | 3,900 | $30.25 | $117,975 | 0 Direct | -100.00% | Disposed | -95.6% (price as of 2026-08-21) |
| Aug. 9, 2021 | PMVP | S 10b5-1 | 224 | $36.69 | $8,219 | 0 Direct | -100.00% | Disposed | -96.4% (price as of 2026-08-21) |
| Aug. 9, 2021 | PMVP | S 10b5-1 | 2,049 | $32.66 | $66,920 | 224 Direct | -90.15% | Disposed | -95.9% (price as of 2026-08-21) |
| Aug. 9, 2021 | PMVP | S 10b5-1 | 2,198 | $35.06 | $77,062 | 1,802 Direct | -54.95% | Disposed | -96.2% (price as of 2026-08-21) |
| July 7, 2021 | PMVP | S 10b5-1 | 2,049 | $32.66 | $66,920 | 0 Direct | -100.00% | Disposed | -95.9% (price as of 2026-08-21) |
| July 7, 2021 | PMVP | S 10b5-1 | 1,951 | $31.93 | $62,295 | 2,049 Direct | -48.77% | Disposed | -95.9% (price as of 2026-08-21) |
| June 7, 2021 | PMVP | S 10b5-1 | 1,367 | $34.00 | $46,478 | 0 Direct | -100.00% | Disposed | -96.1% (price as of 2026-08-21) |
| June 7, 2021 | PMVP | S 10b5-1 | 2,633 | $33.39 | $87,916 | 1,367 Direct | -65.83% | Disposed | -96.0% (price as of 2026-08-21) |
| May 7, 2021 | PMVP | S 10b5-1 | 158 | $35.49 | $5,607 | 0 Direct | -100.00% | Disposed | -96.3% (price as of 2026-08-21) |
| May 7, 2021 | PMVP | S 10b5-1 | 3,842 | $34.80 | $133,702 | 158 Direct | -96.05% | Disposed | -96.2% (price as of 2026-08-21) |
| April 7, 2021 | PMVP | S 10b5-1 | 28 | $34.42 | $964 | 0 Direct | -100.00% | Disposed | -96.2% (price as of 2026-08-21) |
| April 7, 2021 | PMVP | S 10b5-1 | 3,972 | $33.86 | $134,492 | 28 Direct | -99.30% | Disposed | -96.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 12, 2023 | PMVP | Employee Stock Option (right to buy) | Common Stock (100,000) | $5.70 | May 12, 2033 | 100,000 | Acquired |
| Feb. 10, 2022 | PMVP | Employee Stock Option (right to buy) | Common Stock (104,400) | $16.29 | Feb. 10, 2032 | 104,400 | Acquired |
| Sept. 9, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (100) | $3.90 | Feb. 4, 2030 | 100 | Disposed |
| Sept. 7, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (3,900) | $3.90 | Feb. 4, 2030 | 3,900 | Disposed |
| Aug. 9, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (4,000) | $3.90 | Feb. 4, 2030 | 4,000 | Disposed |
| July 7, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (4,000) | $3.90 | Feb. 4, 2030 | 4,000 | Disposed |
| June 7, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (4,000) | $3.90 | Feb. 4, 2030 | 4,000 | Disposed |
| May 12, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (36,279) | $28.33 | May 11, 2031 | 36,279 | Acquired |
| May 7, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (4,000) | $3.90 | Feb. 4, 2030 | 4,000 | Disposed |
| April 7, 2021 | PMVP | Employee Stock Option (right to buy) | Common Stock (4,000) | $3.90 | Feb. 4, 2030 | 4,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 24, 2020 | PMVP | Stock Option (right to buy)→ Common Stock (377,850) | 377,850 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PMVP
M.D.Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $469,758 | — | $710,964 | $1,177,183 | $132,174 | — | — | $2,490,079 |
| 2021 | $456,083 | — | — | $715,059 | $229,150 | — | — | $1,400,292 |
| 2020 | $445,000 | — | — | — | $184,675 | — | — | $1,547,649 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.